Corriente Advisors

Omnitron Sensors is a developer of advanced sensor technology aimed at enhancing the safety and autonomy of self-driving cars and drones. The company specializes in silicon photonics processes to create high-performance and cost-effective sensors that are essential for safety-critical applications. By providing tools that facilitate full autonomy, Omnitron Sensors enables clients to implement reliable solutions for driverless vehicles, ensuring safe navigation in various environments.

Omnitron Sensors is a developer of advanced sensor technology aimed at enhancing the safety and autonomy of self-driving cars and drones. The company specializes in silicon photonics processes to create high-performance and cost-effective sensors that are essential for safety-critical applications. By providing tools that facilitate full autonomy, Omnitron Sensors enables clients to implement reliable solutions for driverless vehicles, ensuring safe navigation in various environments.

Neurologix, Inc., a development stage company, engages in the discovery and development of therapeutic treatments for disorders of the brain and central nervous system. The company's treatments are designed as alternatives to conventional surgical and pharmacological treatments. It primarily focuses on gene therapy for treating Parkinson's disease, a neurodegenerative disorder; and epilepsy, a group of diseases associated with recurrent seizures, which is caused by periodic episodes of repetitive, abnormal electrochemical disturbance in the central nervous system, beginning in the brain. The company also focuses on the development of gene transfers for the treatment of neurodegenerative and metabolic disorders, including Huntington's disease, depression, and metabolic syndrome or genetically-based obesity. Neurologix, Inc. was founded in 1999 and is based in Fort Lee, New Jersey.